サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434995

光線性角化症治療市場：疾患タイプ、治療法、エンドユーザー別-2024-2030年の世界予測

Actinic Keratosis Treatment Market by Disease Type (Clinical AK, Subclinical AK), Treatment (Medication, Surgery), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
光線性角化症治療市場：疾患タイプ、治療法、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

光線性角化症治療市場規模は2023年に62億1,000万米ドルと推計され、2024年には64億8,000万米ドルに達し、CAGR 4.37%で2030年には83億8,000万米ドルに達すると予測されます。

光線性角化症治療の世界市場

主な市場の統計
基準年[2023］ 62億1,000万米ドル
予測年[2024］ 64億8,000万米ドル
予測年 [2030] 83億8,000万米ドル
CAGR（%） 4.37%
光線性角化症治療 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは光線性角化症治療市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、光線性角化症治療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-光線性角化症治療市場の市場規模および予測は？

2-光線性角化症治療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-光線性角化症治療市場における技術動向と規制の枠組みは？

4-光線性角化症治療市場における主要ベンダーの市場シェアは？

5-光線性角化症治療市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 日光角化症と皮膚がんの症例数の増加
      • アウトドアスポーツ活動の嗜好の高まりと発展
      • 消費者の皮膚疾患に対する認識の加速
    • 抑制要因
      • 光線性角化症治療に関連する健康への悪影響
    • 機会
      • 光線角化症の外用薬と治療薬の承認が急増
      • 日光角化症および非黒色腫皮膚がんの治療のための光線力学療法は進歩を続けています
    • 課題
      • 光線性角化症治療の標準化の欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 光線性角化症治療市場：疾患タイプ別

  • 臨床AK
  • 無症候性AK

第7章 光線性角化症治療市場治療別

  • 薬
    • 薬用クリームまたはジェル
      • フルオロウラシル
      • イミキモド
      • メブ酸インゲノールまたはジクロフェナク
  • 手術
    • 凍結療法
    • 掻爬術
    • レーザー治療
    • 光線力学療法

第8章 光線性角化症治療市場：エンドユーザー別

  • がん治療センター
  • ホームケア
  • 病院
  • レーザー治療センター
  • 私立皮膚科クリニック
  • スパ &リジュビネーションセンター

第9章 南北アメリカの光線性角化症治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の光線性角化症治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの光線性角化症治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Accord Healthcare, Inc.
    • AdipoGen Life Sciences
    • Almirall, S.A.
    • Athenex, Inc.
    • Bausch Health Companies, Inc.
    • Biofrontera AG
    • Enzo Life Sciences Inc.
    • Fresenius Kabi
    • Galderma SA
    • Glenmark Pharmaceuticals Limited
    • Hill Dermaceuticals, Inc.
    • LEO Pharma A/S.
    • Merck KGaA
    • Novartis AG
    • Perrigo Company PLC
    • Sagent Pharmaceuticals, Inc.
    • Spear Dermatology Products, Inc.
    • Stanford Chemicals Company
    • Strides Pharma Science Limited
    • Sun Pharmaceutical Industries Ltd.
    • Taj Pharmaceuticals Ltd.
    • Taro Pharmaceutical Industries Ltd.
    • Viatris, Inc.
    • Xiromed LLC
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ACTINIC KERATOSIS TREATMENT MARKET DYNAMICS
  • FIGURE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ACTINIC KERATOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SUBCLINICAL AK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 9. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 13. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE OR DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 18. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CANCER TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRIVATE DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SPAS & REJUVENATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY MEDICATED CREAM OR GEL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 280. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 281. ACTINIC KERATOSIS TREATMENT MARKET LICENSE & PRICING
目次
Product Code: MRR-B16853776D0C

[185 Pages Report] The Actinic Keratosis Treatment Market size was estimated at USD 6.21 billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 4.37% to reach USD 8.38 billion by 2030.

Global Actinic Keratosis Treatment Market

KEY MARKET STATISTICS
Base Year [2023] USD 6.21 billion
Estimated Year [2024] USD 6.48 billion
Forecast Year [2030] USD 8.38 billion
CAGR (%) 4.37%
Actinic Keratosis Treatment Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Actinic Keratosis Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Actinic Keratosis Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Actinic Keratosis Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Accord Healthcare, Inc., AdipoGen Life Sciences, Almirall, S.A., Athenex, Inc., Bausch Health Companies, Inc., Biofrontera AG, Enzo Life Sciences Inc., Fresenius Kabi, Galderma SA, Glenmark Pharmaceuticals Limited, Hill Dermaceuticals, Inc., LEO Pharma A/S., Merck KGaA, Novartis AG, Perrigo Company PLC, Sagent Pharmaceuticals, Inc., Spear Dermatology Products, Inc., Stanford Chemicals Company, Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., Taro Pharmaceutical Industries Ltd., Viatris, Inc., and Xiromed LLC.

Market Segmentation & Coverage

This research report categorizes the Actinic Keratosis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Clinical AK
    • Subclinical AK
  • Treatment
    • Medication
      • Medicated Cream or Gel
        • Fluorouracil
        • Imiquimod
        • Ingenol Mebutate or Diclofenac
    • Surgery
      • Cryotherapy
      • Curettage
      • Laser Therapy
      • Photodynamic Therapy
  • End-User
    • Cancer Treatment Centers
    • Homecare
    • Hospitals
    • Laser Therapy Centers
    • Private Dermatology Clinics
    • Spas & Rejuvenation Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Actinic Keratosis Treatment Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Actinic Keratosis Treatment Market?

3. What are the technology trends and regulatory frameworks in the Actinic Keratosis Treatment Market?

4. What is the market share of the leading vendors in the Actinic Keratosis Treatment Market?

5. Which modes and strategic moves are suitable for entering the Actinic Keratosis Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Actinic Keratosis Treatment Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cases of actinic keratosis and skin cancer
      • 5.1.1.2. Growing preference and development of outdoor sports activities
      • 5.1.1.3. Accelerated awareness among consumers for dermatological disease
    • 5.1.2. Restraints
      • 5.1.2.1. Associated adverse health impacts of actinic keratosis treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in approvals of topical agents and treatment for actinic keratosis
      • 5.1.3.2. Ongoing advances in photodynamic therapy for the treatment of actinic keratosis and nonmelanoma skin cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardizations for actinic keratosis treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Actinic Keratosis Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Clinical AK
  • 6.3. Subclinical AK

7. Actinic Keratosis Treatment Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medication
    • 7.3.1. Medicated Cream or Gel
      • 7.3.2.1. Fluorouracil
      • 7.3.2.2. Imiquimod
      • 7.3.2.3. Ingenol Mebutate or Diclofenac
  • 7.3. Surgery
    • 7.4.1. Cryotherapy
    • 7.4.2. Curettage
    • 7.4.3. Laser Therapy
    • 7.4.4. Photodynamic Therapy

8. Actinic Keratosis Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Cancer Treatment Centers
  • 8.3. Homecare
  • 8.4. Hospitals
  • 8.5. Laser Therapy Centers
  • 8.6. Private Dermatology Clinics
  • 8.7. Spas & Rejuvenation Centers

9. Americas Actinic Keratosis Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Actinic Keratosis Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Actinic Keratosis Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3M Company
    • 13.1.2. Accord Healthcare, Inc.
    • 13.1.3. AdipoGen Life Sciences
    • 13.1.4. Almirall, S.A.
    • 13.1.5. Athenex, Inc.
    • 13.1.6. Bausch Health Companies, Inc.
    • 13.1.7. Biofrontera AG
    • 13.1.8. Enzo Life Sciences Inc.
    • 13.1.9. Fresenius Kabi
    • 13.1.10. Galderma SA
    • 13.1.11. Glenmark Pharmaceuticals Limited
    • 13.1.12. Hill Dermaceuticals, Inc.
    • 13.1.13. LEO Pharma A/S.
    • 13.1.14. Merck KGaA
    • 13.1.15. Novartis AG
    • 13.1.16. Perrigo Company PLC
    • 13.1.17. Sagent Pharmaceuticals, Inc.
    • 13.1.18. Spear Dermatology Products, Inc.
    • 13.1.19. Stanford Chemicals Company
    • 13.1.20. Strides Pharma Science Limited
    • 13.1.21. Sun Pharmaceutical Industries Ltd.
    • 13.1.22. Taj Pharmaceuticals Ltd.
    • 13.1.23. Taro Pharmaceutical Industries Ltd.
    • 13.1.24. Viatris, Inc.
    • 13.1.25. Xiromed LLC
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing